Home > Healthcare > Biotechnology > Bioservices > Biobanking Market
Biobanking Market Share
- Report ID: GMI6534
- Published Date: Aug 2023
- Report Format: PDF
Biobanking Market Share
The prominent players in biobanking market are
- Thermo Fisher Scientific, Inc.
- PHC Holdings Corporation
- Hamilton Company
- Avantor Inc.
- Qiagen N.V.
- Tecan Trading AG
- Merck & Co., Inc.
- Becton
- Dickinson and Company
- Cryoport Inc.
- Azenta Inc.
These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches to maintain a competitive edge in the industry.
Frequently Asked Questions (FAQ) :
The biobanking industry size was USD 62.6 billion in 2022 and is predicted to experience a sustainable growth of CAGR 7.2% from 2023 to 2032.
The equipment segment accounted for the largest market share of 52.4% in 2022 and is expected to record around 7.3% CAGR from 2023 to 2032 attributed to the rapid increase in the number of new biobanks.
North America biobanking market size was around USD 20.2 billion, and it is expected to reach USD 41.5 billion by 2032 attributed to factors such as robust & well-established research infrastructure, with numerous renowned academic and research institutions.
Thermo Fisher Scientific, Inc., PHC Holdings Corporation, Hamilton Company, Avantor Inc., Qiagen N.V., Tecan Trading AG, Merck & Co., Inc., Becton, Dickinson and Company, Cryoport Inc., and Azenta Inc.
Biobanking Market Scope
×
Get a free sample of
Biobanking Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below